Thr54 allele of fatty-acid binding protein 2 gene is associated with obesity but not type 2 diabetes mellitus in a Caucasian population

Diabetes Research and Clinical Practice

Volumn 84, Issue 2, 2009, Pages 132-137

  Tavridou, A ^a   Arvanitidis, K I ^a   Tiptiri Kourpeti, A ^a   Petridis, I ^a   Ragia, G ^a   Kyroglou, S ^b   Christakidis, D ^b   Manolopoulos, V G ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b Academic General Hospital Alexandroupolis   (Greece)

Author keywords

A54T polymorphism; Caucasian; FABP2; Obesity; Type 2 diabetes mellitus

Indexed keywords

FATTY ACID BINDING PROTEIN 2;

AGED; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADENINE; AMINO ACID SUBSTITUTION; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FATTY ACID-BINDING PROTEINS; GENOTYPE; HUMANS; OBESITY; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; THREONINE; THYMINE;

EID: 63649096468     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2009.02.022     Document Type: Article

References (35)

1. Sims E.A., Danforth Jr. E., Horton E.S., Bray G.A., Glennon J.A., and Salans L.B. Endocrine and metabolic effects of experimental obesity in man. Recent Prog. Horm. Res. 29 (1973) 457-496
2. Mokdad A.H., Ford E.S., Bowman B.A., Dietz W.H., Vinicor F., Bales V.S., et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289 (2003) 76-79
3. Elbers C.C., Onland-Moret N.C., Franke L., Niehoff A.G., van der Schouw Y.T., and Wijmenga C. A strategy to search for common obesity and type 2 diabetes genes. Trends Endocrinol. Metab. 18 (2007) 19-26
4. Sweetser D.A., Birkenmeier E.H., Klisak I.J., Zollman S., Sparkes R.S., Mohandas T., et al. The human and rodent intestinal fatty acid binding protein genes. A comparative analysis of their structure, expression, and linkage relationships. J. Biol. Chem. 262 (1987) 16060-16071
5. Hertzel A.V., and Bernlohr D.A. The mammalian fatty acid-binding protein multigene family: molecular and genetic insights into function. Trends Endocrinol. Metab. 11 (2000) 175-180
6. Furuhashi M., and Hotamisligil G.S. Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat. Rev. Drug Discov. 7 (2008) 489-503
7. Lowe J.B., Sacchettini J.C., Laposata M., McQuillan J.J., and Gordon J.I. Expression of rat intestinal fatty acid-binding protein in Escherichia coli. Purification and comparison of ligand binding characteristics with that of Escherichia coli-derived rat liver fatty acid-binding protein. J. Biol. Chem. 262 (1987) 5931-5937
8. Darimont C., Gradoux N., Persohn E., Cumin F., and De Pover A. Effects of intestinal fatty acid-binding protein overexpression on fatty acid metabolism in Caco-2 cells. J. Lipid Res. 41 (2000) 84-92
9. Vassileva G., Huwyler L., Poirier K., Agellon L.B., and Toth M.J. The intestinal fatty acid binding protein is not essential for dietary fat absorption in mice. FASEB J. 14 (2000) 2040-2046
10. Zimmerman A.W., and Veerkamp J.H. New insights into the structure and function of fatty acid-binding proteins. Cell Mol. Life Sci. 59 (2002) 1096-1116
11. Weiss E.P., Brown M.D., Shuldiner A.R., and Hagberg J.M. Fatty acid binding protein-2 gene variants and insulin resistance: gene and gene-environment interaction effects. Physiol. Genom. 10 (2002) 145-157
12. Baier L.J., Sacchettini J.C., Knowler W.C., Eads J., Paolisso G., Tataranni P.A., et al. An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. J. Clin. Invest. 95 (1995) 1281-1287
13. Hegele R.A., Harris S.B., Hanley A.J., Sadikian S., Connelly P.W., and Zinman B. Genetic variation of intestinal fatty acid-binding protein associated with variation in body mass in aboriginal Canadians. J. Clin. Endocrinol. Metab. 81 (1996) 4334-4337
14. Albala C., Santos J.L., Cifuentes M., Villarroel A.C., Lera L., Liberman C., et al. Intestinal FABP2 A54T polymorphism: association with insulin resistance and obesity in women. Obes. Res. 12 (2004) 340-345
15. Lei H.H., Coresh J., Shuldiner A.R., Boerwinkle E., and Brancati F.L. Variants of the insulin receptor substrate-1 and fatty acid binding protein 2 genes and the risk of type 2 diabetes, obesity, and hyperinsulinemia in African-Americans: the Atherosclerosis Risk in Communities Study. Diabetes 48 (1999) 1868-1872
16. Sipilainen R., Uusitupa M., Heikkinen S., Rissanen A., and Laakso M. Variants in the human intestinal fatty acid binding protein 2 gene in obese subjects. J. Clin. Endocrinol. Metab. 82 (1997) 2629-2632
17. Fisher E., Li Y., Burwinkel B., Kuhr V., Hoffmann K., Mohlig M., et al. Preliminary evidence of FABP2 A54T polymorphism associated with reduced risk of type 2 diabetes and obesity in women from a German cohort. Horm. Metab. Res. 38 (2006) 341-345
18. Chiu K.C., Chuang L.M., and Yoon C. The A54T polymorphism at the intestinal fatty acid binding protein 2 is associated with insulin resistance in glucose tolerant Caucasians. BMC Genet. 2 (2001) 7
19. Whitley E., and Ball J. Statistics review 4: sample size calculations. Crit. Care 6 (2002) 335-341
20. Pihlajamaki J., Rissanen J., Heikkinen S., Karjalainen L., and Laakso M. Codon 54 polymorphism of the human intestinal fatty acid binding protein 2 gene is associated with dyslipidemias but not with insulin resistance in patients with familial combined hyperlipidemia. Arterioscler. Thromb. Vasc. Biol. 17 (1997) 1039-1044
21. Brown M.D., Shuldiner A.R., Ferrell R.E., Weiss E.P., Korytkowski M.T., Zmuda J.M., et al. FABP2 genotype is associated with insulin sensitivity in older women. Metabolism 50 (2001) 1102-1105
22. Lepretre F., Vionnet N., Budhan S., Dina C., Powell K.L., Genin E., et al. Genetic studies of polymorphisms in ten non-insulin-dependent diabetes mellitus candidate genes in Tamil Indians from Pondichery. Diabetes Metab. 24 (1998) 244-250
23. Yamada K., Yuan X., Ishiyama S., Koyama K., Ichikawa F., Koyanagi A., et al. Association between Ala54Thr substitution of the fatty acid-binding protein 2 gene with insulin resistance and intra-abdominal fat thickness in Japanese men. Diabetologia 40 (1997) 706-710
24. Ito K., Nakatani K., Fujii M., Katsuki A., Tsuchihashi K., Murata K., et al. Codon 54 polymorphism of the fatty acid binding protein gene and insulin resistance in the Japanese population. Diabetes Med. 16 (1999) 119-124
25. Rissanen J., Pihlajamaki J., Heikkinen S., Kekalainen P., Kuusisto J., and Laakso M. The Ala54Thr polymorphism of the fatty acid binding protein 2 gene does not influence insulin sensitivity in Finnish nondiabetic and NIDDM subjects. Diabetes 46 (1997) 711-712
26. Hayakawa T., Nagai Y., Nohara E., Yamashita H., Takamura T., Abe T., et al. Variation of the fatty acid binding protein 2 gene is not associated with obesity and insulin resistance in Japanese subjects. Metabolism 48 (1999) 655-657
27. Takakura Y., Yoshioka K., Umekawa T., Kogure A., Toda H., Yoshikawa T., et al. Thr54 allele of the FABP2 gene affects resting metabolic rate and visceral obesity. Diabetes Res. Clin. Pract. 67 (2005) 36-42
28. de Luis D.A., Sagrado M.G., Aller R., Izaola O., and Conde R. Influence of ALA54THR polymorphism of fatty acid-binding protein 2 on obesity and cardiovascular risk factors. Horm. Metab. Res. 39 (2007) 830-834
29. Weiss E.P., Brandauer J., Kulaputana O., Ghiu I.A., Wohn C.R., Phares D.A., et al. FABP2 Ala54Thr genotype is associated with glucoregulatory function and lipid oxidation after a high-fat meal in sedentary nondiabetic men and women. Am. J. Clin. Nutr. 85 (2007) 102-108
30. Baier L.J., Bogardus C., and Sacchettini J.C. A polymorphism in the human intestinal fatty acid binding protein alters fatty acid transport across Caco-2 cells. J. Biol. Chem. 271 (1996) 10892-10896
31. Levy E., Menard D., Delvin E., Stan S., Mitchell G., Lambert M., et al. The polymorphism at codon 54 of the FABP2 gene increases fat absorption in human intestinal explants. J. Biol. Chem. 276 (2001) 39679-39684
32. Lara-Castro C., Hunter G.R., Lovejoy J.C., Gower B.A., and Fernandez J.R. Association of the intestinal fatty acid-binding protein Ala54Thr polymorphism and abdominal adipose tissue in African-American and Caucasian women. J. Clin. Endocrinol. Metab. 90 (2005) 1196-1201
33. de Luis D.A., Aller R., Izaola O., Sagrado M.G., and Conde R. Influence of ALA54THR polymorphism of fatty acid binding protein 2 on lifestyle modification response in obese subjects. Ann. Nutr. Metab. 50 (2006) 354-360
34. de Luis D.A., Aller R., Izaola O., Sagrado M.G., and Conde R. Influence of Ala54Thr polymorphism of fatty acid-binding protein 2 on weight loss and insulin levels secondary to two hypocaloric diets: a randomized clinical trial. Diabetes Res. Clin. Pract. 82 (2008) 113-118
35. de Luis D.A., Sagrado M.G., Izaola O., Terroba M.C., Cuellar L., Conde R., et al. Influence of Ala54Thr polymorphism of fatty acid-binding protein-2 on clinical results of biliopancreatic diversion. Nutrition 24 (2008) 300-304